New biologics, precision diagnostics, and AI are reshaping care for rare allergies — from eosinophilic esophagitis to drug ...
A highly selective TASK-1 inhibitor designed to restore rhythm and rate with improved safety — moving toward First-in-Human studies OCALA, FL, UNITED STATES, April ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results